B‐cell activating factor, a predictor of antibody mediated rejection in kidney transplantation recipients

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1797|23|2|169-174

ISSN： 1320-5358

Source： NEPHROLOGY, Vol.23, Iss.2, 2018-02, pp. : 169-174

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High B‐cell activating factor is not associated with worse 3‐year graft outcome in blood group‐incompatible kidney transplantation with rituximab induction

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 4, 2015-04 ,pp. : 359-364

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapeutic plasma exchange for kidney transplantation: the problem of antibody‐mediated rejection

By  

TRANSFUSION, Vol. 55, Iss. 4, 2015-04 ,pp. : 696-699

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antibody‐mediated rejection in hand transplantation

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 27, Iss. 2, 2014-02 ,pp. : e13-e17

John Wiley & Sons Inc

Access to resources Recommend Favorite

The impact of C4d‐negative acute antibody‐mediated rejection on short‐term prognosis among kidney transplant recipients

By  

NEPHROLOGY, Vol. 20, Iss. S2, 2015-07 ,pp. : 16-19

John Wiley & Sons Inc

Access to resources Recommend Favorite

Postoperative rebound of antiblood type antibodies and antibody‐mediated rejection after ABO‐incompatible living‐related kidney transplantation

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 3, 2015-03 ,pp. : 286-296

John Wiley & Sons Inc

Access to resources Recommend Favorite